Blue Ridge Bankshares (BRBS) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Announced a private placement with a shareholder, resulting in the issuance of common and preferred stock and warrants for gross proceeds of approximately $11.6 million as of June 13, 2024.
The transaction is part of a larger $150 million private placement, with conversion of preferred shares contingent on shareholder approval and an increase in authorized common shares.
Updated dilution table shows potential for significant increase in outstanding common shares upon full conversion of preferred stock.
Forward-looking statements highlight expectations, plans, and risks related to business operations and financial performance.
Voting matters and shareholder proposals
Shareholder approval is required for the issuance of common shares in excess of 20% of outstanding shares and for increasing authorized common shares from 50 million to 150 million.
Related party transactions
Securities were issued to a shareholder, Richard T. Spurzem, under contractual gross-up rights related to prior agreements.
Latest events from Blue Ridge Bankshares
- Returned to profitability in 2025, lifted consent order, and paid a special dividend.BRBS
Q4 202529 Jan 2026 - Recapitalization registers 97M shares for resale; proceeds support growth, with concentrated ownership.BRBS
Registration Filing16 Dec 2025 - Virtual meeting to vote on directors, expanded stock plan, and auditor ratification amid governance focus.BRBS
Proxy Filing2 Dec 2025 - Shareholders will vote on board declassification, executive pay, and auditor ratification at the 2025 meeting.BRBS
Proxy Filing2 Dec 2025 - Board seeks approval for declassification, executive pay, and auditor ratification at 2025 meeting.BRBS
Proxy Filing2 Dec 2025 - Virtual annual meeting to vote on directors, stock plan, and auditor ratification.BRBS
Proxy Filing2 Dec 2025 - Shareholders to vote on director elections, board declassification, compensation, and auditor ratification.BRBS
Proxy Filing2 Dec 2025 - Q3 2025 net income hit $5.6M, margins rose, and capital remained strong amid strategic changes.BRBS
Q3 202514 Nov 2025 - Q2 2024 net loss of $11.4M, fintech impairment, capital raised, and BaaS exit progress.BRBS
Q2 202417 Oct 2025